# Patient and Provider perspectives on long acting injectable ART

> **NIH NIH R01** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2020 · $636,663

## Abstract

ABSTRACT
 Long-acting injectable antiretroviral therapy (LAI ART) is anticipated to be a major advance in the
management of HIV infection. However, how this therapeutic innovation will be received among patients and
providers remains unclear. At present, there are few data with which to forecast, let alone, plan for incorporation
of this innovation in HIV care into practice. Our preliminary studies demonstrate excitement for LAI ART among
participants in research trials of this mode of ART administration, with possibly less enthusiasm among HIV care
providers. With the proposed research studies, we seek to gain a deeper understanding of the perceptions
regarding LAI ART among diverse groups of PLHIV in the US and their care providers. This understanding will
be used to inform the roll-out of LAI ART, including the development of tools that PLHIV and providers can use
to guide shared decision-making when choosing among treatment options.

## Key facts

- **NIH application ID:** 9929641
- **Project number:** 5R01MH118955-02
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** CLARE L BARRINGTON
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $636,663
- **Award type:** 5
- **Project period:** 2019-05-15 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9929641

## Citation

> US National Institutes of Health, RePORTER application 9929641, Patient and Provider perspectives on long acting injectable ART (5R01MH118955-02). Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/grant/nih/9929641. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*